306 Injectable Solutions: A Handbook for Clinical Compatibility and Administration

Author: Shen Jianping et al.
Publisher:
Publishing Date: Not available
Features: With the rapid development of pharmaceutical technology, a large number of new drugs are continuously applied in clinical practice, while many older drugs are also being repurposed. The compatibility of new and old drugs, as well as the safety and efficacy of their combined use, are challenging and complex issues often encountered in clinical treatment. To facilitate rational drug use in clinical practice, we have built upon the original "256 Drug Compatibility Reference for Intravenous Solutions" and introduced a wealth of new information on drug compatibility and recent experimental conclusions. We have excluded 40 outdated or rarely used intravenous solutions from the original table, while adding 90 newly launched and used intravenous solutions in recent years. Based on this, we have rewritten the "306 Drug Compatibility Reference for Clinical Use" and its companion "306 Drug Compatibility Handbook for Clinical Use," designed for healthcare professionals. Additionally, we have included 14 supplementary tables at the end of the book to provide colleagues with a safer, more effective, comprehensive, and convenient clinical drug compatibility tool.
Science is constantly advancing and has no end. The clinical application of drugs is also a dynamic and evolving process. In the compilation of this handbook, in addition to referencing the physicochemical aspects of drug compatibility, we have also extensively consulted research findings related to the 306 intravenous solutions covered in the table, including pharmacology, pharmacodynamics, pharmacokinetics, clinical pharmacy, toxicology, and pharmaceutical analysis. We have made every effort to clearly indicate the changes in pharmacological effects, pharmacodynamics, pharmacokinetics, chemical interactions, analytical results, and toxicology that may occur after drug compatibility.
Due to differences in information coverage, analytical approaches, experimental drugs, and conditions, the outcomes of drug compatibility may vary significantly from previous conclusions regarding intravenous solutions. In some cases, the differences may even be substantial. We urge all colleagues to carefully read the product specifications during clinical use and fully consider factors such as individual patient differences, product quality, and formulations. Adhere to the actual changes in drug compatibility to ensure patient safety and efficacy.
We sincerely welcome any criticism and suggestions from readers for the imperfections in this book.